Figure 7

Gene mutation frequency, tumour mutation burden (TMB), MSI status, and immune escape analysis in the risk-prognostic signature. Analysis of gene mutation frequencies in the (a) low- and (b) high-risk groups. (c) Survival analysis of TMB. (d) Survival analysis of TMB combined with risk score. (e) Relationship between MSI status and risk score. (f) Analysis of differences in risk scores for different immunotherapy responses.